BSE Live
Dec 02, 16:01Prev. Close
2229.90
Open Price
2230.15
Bid Price (Qty.)
2216.70 (18)
Offer Price (Qty.)
2226.85 (1)
NSE Live
Dec 02, 15:41Prev. Close
2229.80
Open Price
2240.10
Bid Price (Qty.)
2216.40 (32)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,524.78 | 2,399.36 | 1,671.24 | 1,974.60 | 1,691.61 | |
| Net CashFlow From Operating Activities | 2,413.38 | 2,152.45 | 1,813.30 | 919.78 | 1,137.24 | |
| Net Cash Used In Investing Activities | -12,682.95 | -2,081.69 | -1,054.13 | -1,369.14 | -1,222.21 | |
| Net Cash Used From Financing Activities | 10,232.56 | 5.27 | -739.73 | 604.62 | -7.81 | |
| Foreign Exchange Gains / Losses | 1.31 | 1.17 | 2.32 | 0.48 | 0.38 | |
| Adjustments On Amalgamation Merger Demerger Others | 57.57 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 21.87 | 77.19 | 21.76 | 155.73 | -92.40 | |
| Cash And Cash Equivalents Begin of Year | 382.01 | 304.82 | 283.06 | 127.33 | 219.73 | |
| Cash And Cash Equivalents End Of Year | 403.88 | 382.01 | 304.82 | 283.06 | 127.33 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y